NCT05779384View on ClinicalTrials.gov

The COPD Attack Study

CompletedOBSERVATIONAL
Enrollment

323

Participants

Timeline

Start Date

July 7, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Pulmonary Disease, Chronic ObstructiveExacerbation COPD
Interventions
OTHER

It was an observational study

data collected concerning the incidence of exacerbations

Trial Locations (2)

256

Makerere University college of health sciences, Mulago National Referal Hospital Complex, Kampala

Makerere University Lung Institute, Kampala

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

University College, London

OTHER

lead

Makerere University

OTHER

NCT05779384 - The COPD Attack Study | Biotech Hunter | Biotech Hunter